about
Immune response to 2009 pandemic H1N1 influenza virus A monovalent vaccine in children with cancer.Clinical features, prognostic factors, and their relationship with antiplatelet antibodies in children with immune thrombocytopenia.Clinical manifestations and outcomes of pediatric chronic neutropenia.Clinical features and major histocompatibility complex genes as potential susceptibility factors in pediatric immune thrombocytopenia.Expression and prognostic significance of the apoptotic genes BCL2L13, Livin, and CASP8AP2 in childhood acute lymphoblastic leukemia.GALNT2 suppresses malignant phenotypes through IGF-1 receptor and predicts favorable prognosis in neuroblastoma.The long-term efficacy and tolerability of oral deferasirox for patients with transfusion-dependent β-thalassemia in Taiwan.Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma.Spatial repolarization heterogeneity detected by magnetocardiography correlates with cardiac iron overload and adverse cardiac events in beta-thalassemia major.A multidisciplinary team care approach improves outcomes in high-risk pediatric neuroblastoma patients.Improved efficacy and tolerability of oral deferasirox by twice-daily dosing for patients with transfusion-dependent β-thalassemia.Breath-hold spin echosequence for assessing liver iron content.β-1,4-Galactosyltransferase III enhances invasive phenotypes via β1-integrin and predicts poor prognosis in neuroblastoma.Absence of biallelic TCRγ deletion predicts induction failure and poorer outcomes in childhood T-cell acute lymphoblastic leukemia.IKZF1 deletions predict a poor prognosis in children with B-cell progenitor acute lymphoblastic leukemia: a multicenter analysis in Taiwan.Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis.Infectious complications in children with acute lymphoblastic leukemia treated with the Taiwan Pediatric Oncology Group protocol: A 16-year tertiary single-institution experience.Clinical characteristics and outcome of invasive fungal infections in pediatric acute myeloid leukemia patients in a medical center in Taiwan.Differentiating juvenile myelomonocytic leukemia from chronic myeloid leukemia in childhood.Gliomatosis cerebri with spinal metastasis presenting with chronic meningitis in two boys.Efficacy of rabbit antithymocyte globulin as first-line treatment of severe aplastic anemia: an Asian multicenter retrospective study.Long-term outcome for Down syndrome patients with hematopoietic disorders.Risk factors and outcomes of cytomegalovirus viremia in pediatric hematopoietic stem cell transplantation patients.Tet oncogene family member 2 gene alterations in childhood acute myeloid leukemia.Severe bacterial infection in transfusion-dependent patients with thalassemia major.Prognostic roles of pathology markers immunoexpression and clinical parameters in Hepatoblastoma.Transfusion-dependent thalassaemic patients with renal Fanconi syndrome due to deferasirox use.Successful treatment of disseminated mixed invasive fungal infection after hematopoietic stem cell transplantation for severe aplastic anemia.Cardiac iron measurement and iron chelation therapy in patients with β thalassaemia major: experience from Taiwan.Characterization of neuroblastic tumors using 18F-FDOPA PET.Cytogenetics in childhood acute lymphoblastic leukemia in Taiwan: a single-institutional experience.Forty-seven children suffering from chronic myeloid leukemia at a center over a 25-year period.Retrospective analysis of the renal outcome of pediatric lupus nephritis.Improved treatment results for childhood acute myeloid leukemia in Taiwan.Inhibitory effect of pooled human immunoglobulin on cytokine production in peripheral blood mononuclear cells.Pediatric acute lymphoblastic leukemia with t(1;19)/TCF3-PBX1 in Taiwan.Treatment for childhood acute lymphoblastic leukemia in Taiwan: Taiwan Pediatric Oncology Group ALL-2002 study emphasizing optimal reinduction therapy and central nervous system preventive therapy without cranial radiation.Simultaneous Determination of Plasma Deferasirox and Deferasirox-Iron Complex Using an HPLC-UV System and Pharmacokinetics of Deferasirox in Patients With β-Thalassemia Major: Once-daily Versus Twice-daily Administration.Incidence of cancer in children aged 0-14 years in Taiwan, 1996-2010.Hemorrhagic cystitis in children treated with alkylating agent cyclophosphamide: The experience of a medical center in Taiwan.
P50
Q30401024-0357169A-5C09-4801-A545-97D5794FE8B5Q33399025-59883369-75CF-4473-B7F6-0F3CED48D3E3Q33400873-AEC3A740-0C1B-473D-B27C-DCC370A32F8AQ33402462-4B46B997-A47B-4FF4-9152-251894BD9C02Q34095354-93A0073A-A358-4D7C-B5C1-55BAFFBFED5CQ35067906-271DC0C4-7DB6-4405-B83D-3A05386862DDQ36158835-9467FEBF-2189-42D8-98D6-7C80BB6F9091Q37109868-8359ECC5-AC4B-41F8-8412-9D03EBAF22CEQ37520798-73268B92-6C4C-45CA-99E4-10AE23A1A04DQ37706191-8EA19CDF-0A8D-4176-A275-04230E1BC6C5Q37809009-401DD67A-3ECA-4868-8C28-B4CACB513F52Q38906758-18B3AC5C-84BA-474A-91FF-670E9A24137BQ39187979-7A6E245D-16D0-498A-A467-58A2B1A4194BQ39674477-EF9F84D6-223C-4B66-8C85-A66C8D3D0D6CQ39730823-98D7B8E5-49C7-41DA-9C5E-A30899359207Q39933548-0A0E8DEB-0D07-4CC1-BDAC-2B7DDBABF471Q40062706-1BA0E90E-4E73-44A1-AF02-2A88BB92766CQ40371441-A28AE866-6C70-4D19-B24D-D143A680C80BQ40535836-04A18784-2728-42DC-84C6-F379E65A30CEQ40595376-0328D195-9FCE-47DC-8931-8D8E42BE238CQ40668046-242E4393-D6B5-4DE8-9F7A-C019BA6F4631Q40669415-F7828019-B45B-4645-80B8-257EFAE300ABQ41011887-787F6060-8818-490D-8799-B36A6110B35DQ41297543-E2553E72-DB7A-459E-8AA4-B3CCF935CC58Q41465572-254BEF8A-92AB-4CFD-ADD2-18AA2268DEACQ41542757-78C80694-2F68-4901-8BEF-F89E1AE3772FQ41714289-4768A8FD-67AF-43CA-84F5-ED68225EDF7AQ43604106-C59747B1-ABE5-4B9A-AA6A-896ECD092B7CQ44142481-472022BD-9467-433D-A1F7-A03D8F444AEBQ44201943-F3247651-9ADF-42B4-9C8E-1AD9D44DF1BFQ44516173-1AA7B90F-EFEE-4396-81CB-B7395D999918Q44575935-2864FF90-5376-4F41-BADC-AE487CFE1279Q45006574-7DE9EC71-AC87-41CD-8AEB-B1DA392278A8Q46799056-2D735AE2-1DE5-4127-A918-C418E9EECB8AQ46903581-9771A21C-AE51-4424-B49C-A145D31EA0E7Q47908187-A1B7D5D7-33E2-4BDD-A470-CC39EB608871Q48039932-85E34CF3-F5EF-4F06-8DE1-DD8579B418E2Q50961601-599AF92D-7B1E-4FC4-ADC1-D06F08A9AE40Q51063152-64794A7F-0C25-4B77-95C9-F3311E85F505Q51795961-40FA505D-8919-4984-9F4F-59B6529F98D1
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Meng-Yao Lu
@ast
Meng-Yao Lu
@en
Meng-Yao Lu
@es
Meng-Yao Lu
@nl
type
label
Meng-Yao Lu
@ast
Meng-Yao Lu
@en
Meng-Yao Lu
@es
Meng-Yao Lu
@nl
prefLabel
Meng-Yao Lu
@ast
Meng-Yao Lu
@en
Meng-Yao Lu
@es
Meng-Yao Lu
@nl
P106
P1153
35322611200
P31
P496
0000-0003-4461-9967